NEW YORK, Oct 23 - Packard BioScience said Monday its wholly-owned subsidiary BioSignal Packard had entered into a $5.5 million proteomics contract with Astra Zeneca's R&D arm in St. Laurent, Quebec.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.